contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


report-from-the-extraordinary-general-meeting-of-biokraft-international-ab-publ

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

Scandinavian Biogas Fuels International

Stockholm, 27 March 2024Biokraft International AB (publ), reg.no 556528-4733, has today held an extraordinary general meeting, at which the following was resolved. The meeting was conducted ...

<div class="abstract">Stockholm, 27 March 2024</div>Biokraft International AB (publ), reg.no 556528-4733, has today held an extraordinary general meeting, at which the following was resolved. The meeting was conducted with the possibility to participate through postal voting.Resolutions to amend the Articles of AssociationThe extraordinary general meeting resolved, in accordance with the Board of Directors' proposal, to amend the company's Articles of Association, whereby the limits of the share capital are changed to a minimum of SEK 87,000,000 and a maximum of SEK 348,000,000 and the number of shares to a minimum of SEK 43,500,000 and a maximum of SEK 174,000,000.The Board of Directors' proposal for a possible second amendment of the Articles of Association to enable issues larger than what can be accommodated within the Board of Director's first proposal to amend the Articles of Association, did not reach the required majority and was therefore not adopted.Issue authorisationsThe Board of Directors' proposal to authorise the Board of Directors to, on one or more occasions during the period until the next annual general meeting, resolve on a rights issue of shares with pre-emptive rights for the company's existing shareholders of a total amount of up to approximately SEK 650 million, after deduction of issue costs, to finance repurchase of its senior secured green bonds did not reach the required majority and was therefore not adopted.This means that the intended rights issue announced by the company on 26 February 2024 will not be conducted.The extraordinary general meeting resolved, in accordance with the Board of Directors' proposal, to authorise the Board of Directors to, on one or more occasions during the period until the next annual general meeting, resolve to issue new shares with or without pre-emptive rights for the company's existing shareholders. Share issues both with and without pre-emptive rights for the company's existing shareholders, by virtue of the authorisation, may amount to a total of up to approximately SEK 150 million to be used for investments in the company's ongoing operations as well as for further growth and expansion. The authorisation replaces the current existing issue authorization as resolved at the annual general meeting 2023.The information was submitted, through the care of the contact person below, for publication on 27 March 2024, at 10:35&nbsp;CET.

Report from the extraordinary general meeting of Biokraft International AB (publ)

Beställ vårt nyhetsbrev — inget användarkonto krävs!